MedPath

EFFECT OF KUSHMANDA GHRITA IN EPILEPTIC CHILD

Not Applicable
Conditions
Health Condition 1: G403- Generalized idiopathic epilepsy and epileptic syndromes
Registration Number
CTRI/2021/02/031046
Lead Sponsor
State Ayurvedic College and Hospital Lucknow
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1 Children aged between 5 - 14 years of age with clinical features.

2 Children clinically diagnosed with epilepsy and verified with diagnostic parameters.

3 Children having frequency of seizural attacks not less than once in 30 days.

4 Patients who are on AEDs and facing cognitive, behavioural or psychological adverse effect without disturbing their regular medicine.

Exclusion Criteria

1 Age <5 year and >14 years.

2 Children not fulfilling the screening criteria.

3 Children with chronic ailments like tuberculosis, malignancy etc and any other congenital syndromic disorder.

4 Children having frequency of seizures attack one in more than 30 days.

5 Patients not regular in the treatment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
THE RESEARCH DRUG IS EXPECTED TO BE BENEFICIAL FOR IMPROVING THE SYMPTOMS OF EPILEPSY LIKE FREQUENCY,SEVERITY , DURATION ETCTimepoint: 3 months
Secondary Outcome Measures
NameTimeMethod
BY THE USE OF THIS GHRITA CHILD GROWS RAPIDLY AND SPEAKS PROPERLY,CURED DEPRESSION AND CALMS THE MINDTimepoint: 3 MONTHS
© Copyright 2025. All Rights Reserved by MedPath